And who would like to enhance the publicity for this one?
Found the following while going to and fro, mostly fro. I've never heard of Techniclone before but they appear to have just made a significant step forward. This is the sort of promise that I find interesting in companies like Univec, Fountain Pharmaceuticals, etc.
Techniclone Corporation (NASDAQ:TCLN), a cancer therapeutics company, announced today that it has entered into a long-range exclusive research and development contract with the Paul Scherrer Institute (PSI) based in Switzerland, for the expansion of the Company's antibody radiolabeling capabilities for LYM-1 and Tumor Necrosis Therapy (TNT)
``After conducting a global survey of potential development partners, we found PSI was unparalleled in its achievements regarding the automation of radiolabeling operations, previous experience with other radiopharmaceutical manufacturers, large scale development capabilities, and superior reputation in both academic and industrial sectors,'' said David R. Allen, Ph.D., Executive Vice President, Operations at Techniclone. ``With PSI assisting our radiopharmaceutical development team, we believe we possess a unique opportunity for acceleration of LYM-1 and TNT development efforts on a worldwide basis.''
Best wishes,
Peter |
